Related Experiment Videos
Psychoeducative groups help control type 2 diabetes in a primary care setting.
Miguel Ángel Cervantes Cuesta1, Noelia Victoria García-Talavera Espín, Josefa Brotons Román
1Primary Care centre, Murcia, Spain.
Nutricion Hospitalaria
|July 5, 2013
Summary
Psychoeducational group therapy significantly improved diabetes management, including HbA1c, BMI, and cardiovascular risk factors, outperforming conventional education. This suggests a need for integrating group interventions into primary care for better diabetes control.
Area of Science:
- Endocrinology
- Public Health
- Behavioral Medicine
Background:
- Diabetes mellitus management requires effective patient education strategies.
- Conventional diabetes education often involves individual counseling.
- Assessing novel interventions like group psychoeducation is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the impact of a psychoeducational group intervention (PGT) on diabetes management.
- To compare PGT with conventional individual diabetes education.
- To measure changes in glycosylated haemoglobin (HbA1c), body mass index (BMI), and cardiovascular risk factors (CVRF).
Main Methods:
- A quasi-experimental study with a non-equivalent control group design.
- Inclusion of 72 individuals with type 2 diabetes (mean age 63.08 years, HbA1c 6.98%, BMI 30.48 kg/m2).
- Comparison between a psychoeducational group therapy (PGT) group and a conventional education (CG) group.
Main Results:
- PGT demonstrated a significantly greater reduction in HbA1c (-0.51% vs. -0.06%, p=0.003) and higher achievement of optimal HbA1c control (80% vs. 48%, p=0.005).
- PGT resulted in greater mean weight reduction (-1.93 kg vs. 0.52 kg, p=0.0002).
- Significant improvements in total cholesterol, LDL cholesterol, triglycerides, and blood pressure were observed in the PGT group (all p < 0.05).
Conclusions:
- Psychoeducational group therapy leads to significant improvements in HbA1c, BMI, and CVRF in type 2 diabetes patients.
- PGT is more effective than conventional diabetes education in achieving optimal diabetes control objectives.
- Healthcare systems should consider incorporating PGT into primary care diabetes assistance programs for enhanced patient outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...